Urogen Pharma Ltd.

Urogen Pharma Ltd. annual/quarterly operating income history and growth rate from 2016 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.

• Urogen Pharma Ltd. operating income for the quarter ending March 31, 2026 was -20.3 M, a 45.11% decrease year-over-year.
• Urogen Pharma Ltd. operating income for the twelve months ending March 31, 2026 was -126.0 M, a 52.51% increase year-over-year.
• Urogen Pharma Ltd. annual operating income for 2025 was -124.9 M, a 29.01% increase from 2024.
• Urogen Pharma Ltd. annual operating income for 2024 was -96.8 M, a 47.68% increase from 2023.
• Urogen Pharma Ltd. annual operating income for 2023 was -65.5 M, a 17.09% decrease from 2022.
• Urogen Pharma Ltd. annual operating income for 2022 was -79.0 M.